Correlation Between Caribou Biosciences and Opthea

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Opthea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Opthea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Opthea, you can compare the effects of market volatilities on Caribou Biosciences and Opthea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Opthea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Opthea.

Diversification Opportunities for Caribou Biosciences and Opthea

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Caribou and Opthea is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Opthea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opthea and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Opthea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opthea has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Opthea go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Opthea

Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Opthea. In addition to that, Caribou Biosciences is 1.3 times more volatile than Opthea. It trades about -0.06 of its total potential returns per unit of risk. Opthea is currently generating about 0.03 per unit of volatility. If you would invest  295.00  in Opthea on September 24, 2024 and sell it today you would earn a total of  39.00  from holding Opthea or generate 13.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy97.99%
ValuesDaily Returns

Caribou Biosciences  vs.  Opthea

 Performance 
       Timeline  
Caribou Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Caribou Biosciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Opthea 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opthea has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Caribou Biosciences and Opthea Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caribou Biosciences and Opthea

The main advantage of trading using opposite Caribou Biosciences and Opthea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Opthea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opthea will offset losses from the drop in Opthea's long position.
The idea behind Caribou Biosciences and Opthea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios